239 related articles for article (PubMed ID: 3470172)
1. Follow-up of colorectal cancer resected for cure. An experience with CEA, TPA, Ca 19-9 analysis and second-look surgery.
Fucini C; Tommasi SM; Rosi S; Malatantis G; Cardona G; Panichi S; Bettini U
Dis Colon Rectum; 1987 Apr; 30(4):273-7. PubMed ID: 3470172
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal cancer follow-up: the effectiveness of sequential CEA, TPA and Ca 19-9 evaluation in the early diagnosis of recurrences.
Barillari P; Sammartino P; Cardi M; Ricci M; Gozzo P; Cesareo S; Cerasi A
Aust N Z J Surg; 1991 Sep; 61(9):675-80. PubMed ID: 1877936
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma.
Alvarez JA; Marín J; Jover JM; Fernández R; Fradejas J; Moreno M
Dis Colon Rectum; 1995 May; 38(5):535-42. PubMed ID: 7537651
[TBL] [Abstract][Full Text] [Related]
4. Role of CEA, TPA, and Ca 19-9 in the early detection of localized and diffuse recurrent rectal cancer.
Barillari P; Bolognese A; Chirletti P; Cardi M; Sammartino P; Stipa V
Dis Colon Rectum; 1992 May; 35(5):471-6. PubMed ID: 1568399
[TBL] [Abstract][Full Text] [Related]
5. Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study.
Minton JP; Hoehn JL; Gerber DM; Horsley JS; Connolly DP; Salwan F; Fletcher WS; Cruz AB; Gatchell FG; Oviedo M
Cancer; 1985 Mar; 55(6):1284-90. PubMed ID: 3971297
[TBL] [Abstract][Full Text] [Related]
6. The role of CEA, TPA and CA 19-9 in the early detection of recurrent colorectal cancer.
Barillari P; Ramacciato G; de Angelis R; Gozzo P; Aurello P; Indinnimeo M; Valabrega S; D'Angelo F; Fegiz G
Int J Colorectal Dis; 1989 Dec; 4(4):230-3. PubMed ID: 2693562
[TBL] [Abstract][Full Text] [Related]
7. CEA-directed second-look surgery in the asymptomatic patient after primary resection of colorectal carcinoma.
Martin EW; Minton JP; Carey LC
Ann Surg; 1985 Sep; 202(3):310-7. PubMed ID: 4037904
[TBL] [Abstract][Full Text] [Related]
8. Limitations of CEA monitoring as a guide to second-look surgery in colorectal cancer follow-up.
Fucini C; Tommasi MS; Cardona G; Malatantis G; Panichi S; Bettini U
Tumori; 1983 Aug; 69(4):359-64. PubMed ID: 6623661
[TBL] [Abstract][Full Text] [Related]
9. The role of tumour markers (CEA, TPA, CA 19-9) in colon and rectum carcinomas.
Cangemi V; Volpino P; Fiori E; Giammarco A; Piat G
J Nucl Med Allied Sci; 1987; 31(2):189-93. PubMed ID: 3476692
[No Abstract] [Full Text] [Related]
10. Use of CEA as an indicator of early recurrence and as a guide to a selected second-look procedure in patients with colorectal cancer.
Wanebo JH; Stearns M; Schwartz MK
Ann Surg; 1978 Oct; 188(4):481-93. PubMed ID: 697433
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.
Nicolini A; Caciagli M; Zampieri F; Ciampalini G; Carpi A; Spisni R; Colizzi C
Cancer Detect Prev; 1995; 19(2):183-95. PubMed ID: 7750106
[TBL] [Abstract][Full Text] [Related]
12. [Effectiveness of quarterly assessment of CEA, TPA and GICA serum levels in gastric and colorectal carcinomas: Prospective study of 174 patients undergoing radical surgery].
Barillari P; Ricci M; Broglia S; Manetti G; Cerasi A; Cesareo S; Calcaterra D; Cioè I; Caronna R; Sammartino P
Minerva Chir; 1994 Oct; 49(10):953-61. PubMed ID: 7808670
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of combined CA-19-9 and CEA assay in monitoring recurrences and metastases of colorectal cancer].
Yu BM
Zhonghua Wai Ke Za Zhi; 1992 Dec; 30(12):707-9, 777. PubMed ID: 1339738
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the tumor markers CEA, TPA, and CA 19-9 in colorectal carcinoma.
Putzki H; Student A; Jablonski M; Heymann H
Cancer; 1987 Jan; 59(2):223-6. PubMed ID: 3467817
[TBL] [Abstract][Full Text] [Related]
15. Cost effectiveness of postoperative carcinoembryonic antigen monitoring in colorectal cancer.
Sandler RS; Freund DA; Herbst CA; Sandler DP
Cancer; 1984 Jan; 53(1):193-8. PubMed ID: 6418372
[TBL] [Abstract][Full Text] [Related]
16. Tumor markers carcinoembryonic antigen, tissue polypeptide antigen, and carbohydrate antigen 19/9 in liver diseases.
Putzki H; Ledwoch J; Student A; Jablonski M; Heymann H
J Surg Oncol; 1988 Feb; 37(2):133-5. PubMed ID: 3278167
[TBL] [Abstract][Full Text] [Related]
17. [Effect of serial CEA determination on diagnosis, therapy and prognosis of recurrent colorectal cancer].
Mentges B
Langenbecks Arch Chir; 1988; 373(4):227-34. PubMed ID: 3210846
[TBL] [Abstract][Full Text] [Related]
18. Serial levels of CA 19-9 and CEA in colonic cancer.
Novis BH; Gluck E; Thomas P; Steele GD; Zurawski VR; Stewart R; Lavin PT; Zamcheck N
J Clin Oncol; 1986 Jun; 4(6):987-93. PubMed ID: 2423655
[TBL] [Abstract][Full Text] [Related]
19. Multivariate analysis of a tissue CEA, TPA, and CA 19.9 quantitative study in colorectal cancer patients. A preliminary finding.
Cosimelli M; De Peppo F; Castelli M; Giannarelli D; Schinaia G; Castaldo P; Buttini GL; Sciarretta F; Bigotti G; Di Filippo F
Dis Colon Rectum; 1989 May; 32(5):389-97. PubMed ID: 2714130
[TBL] [Abstract][Full Text] [Related]
20. Serum CEA in the follow-up of colorectal carcinoma: experience in a district general hospital.
Allen-Mersh TG
Ann R Coll Surg Engl; 1984 Jan; 66(1):14-6. PubMed ID: 6691692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
